-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

SVB Leerink Downgrades Graphite Bio to Market Perform, Lowers Price Target to $2

Benzinga · 01/06/2023 06:27
SVB Leerink analyst Mani Foroohar downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform and lowers the price target from $11 to $2.